tirzepatide news update outperformed semaglutide weight-loss drug results in real world patients, study shows F.D.A. Approves New Obesity Drug

GLP-1 Receptor Agonists and Colorectal Cancer Risk in Drug-Naive Patients With Type 2 Diabetes, With and Without Overweight/Obesity. JAMA Oncology

Cardiovascular diseases (CVDs) are the prime cause of morbidity and mortality worldwide (Roth et al., 2020)

The FDA also says telehealth companies are advertising drug products branded with the telehealth firms name or trademark without qualification, implying they are the compounder

Dissolve the Peptide Allow the solution to sit undisturbed until the peptide fully dissolves

Rotate sites weekly to maximize absorption

Lastly, if you are not responding to oral B12 then you may want to consider using B12 shots